Table: Taiko Pharmaceutical -2018/19 parent results

Taiko Pharmaceutical

14/05/2019 07:00

May 14 (Reuters)- 
          Taiko Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2019    Mar 31, 2018   Mar 31, 2020     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             9.92            8.97                                 
                 (+10.6 pct)     (+14.8 pct)                             
  Operating         1.93            1.77                                 
                 (+9.4 pct)      (+30.4 pct)                             
  Recurring         1.79            1.51                                 
                 (+18.1 pct)     (+24.4 pct)                             
  Net               1.33            1.05                                 
                 (+27.1 pct)     (+19.5 pct)                             
  EPS             93.26 yen       74.15 yen                              
  EPS Diluted     93.15 yen       73.84 yen                              
  Ann Div         35.00 yen       25.00 yen      30.00 yen               
  -Q2 Div         10.00 yen          NIL         10.00 yen               
  -Q4 Div         25.00 yen       25.00 yen      20.00 yen               
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T